Dentsply Sirona (XRAY) Falls 2% Following In-Line Q1, Lower Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts XRAY Hot Sheet
EPS Growth %: -38.0%
Financial Fact:
Other expense (income), net: 1.6M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Late Sunday, Dentsply Sirona (NASDAQ: XRAY) reported Q1 EPS of $0.45, in-line with the analyst estimate of $0.45. Revenue for the quarter came in at $956.1 million versus the consensus estimate of $940.8 million.
Dentsply Sirona also said sees FY2018 EPS of $2.55-$2.65, versus the consensus of $2.70.
The Board of Directors authorizes an increase of $500 Million in share repurchase program, bringing total current authorization to $1 billion.
For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Harmony Biosciences (HRMY) Misses Q3 EPS by 30c; Offers Guidance
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Stock BuybacksRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
